Elizabeth Donley—NeuroPoint DX—Implementing Metabolomics for Earlier Detection of Autism Spectrum Disorders

Elizabeth Donley—NeuroPoint DX—Implementing Metabolomics for Earlier Detection of Autism Spectrum Disorders

0 0 2 months ago
0 Plays 0 Downloads
Stemina Biomarker Discovery was founded about 11 years ago by Elizabeth Donley, who aimed to use the study of metabolism (metabolomics) to understand how the underlying biological and biochemical reactions differ between various disorders. Donley works primarily within the neurological disorders division for NeuroPoint DX and is focused on applying metabolomics for the detection of autism spectrum disorders. The most recent paper on the subject looked at amino acid dysregulation in autism ... See More

Find us on Facebook

Copyright 2019 - Spreaker Inc. a Voxnest Company - Create a podcast - New York, NY
Help